These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26641206)

  • 1. Pharmacokinetic investigation of sildenafil using positron emission tomography and determination of its effect on cerebrospinal fluid cGMP levels.
    Gómez-Vallejo V; Ugarte A; García-Barroso C; Cuadrado-Tejedor M; Szczupak B; Dopeso-Reyes IG; Lanciego JL; García-Osta A; Llop J; Oyarzabal J; Franco R
    J Neurochem; 2016 Jan; 136(2):403-15. PubMed ID: 26641206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic guanosine monophosphate modulates accumulation of phosphodiesterase 5 inhibitors in human platelets.
    Bajraktari G; Burhenne J; Bugert P; Haefeli WE; Weiss J
    Biochem Pharmacol; 2017 Dec; 145():54-63. PubMed ID: 28964803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient rise of serum testosterone level after single sildenafil treatment of adult male rats.
    Janjic MM; Stojkov NJ; Bjelic MM; Mihajlovic AI; Andric SA; Kostic TS
    J Sex Med; 2012 Oct; 9(10):2534-43. PubMed ID: 22429315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sildenafil treatment in vivo stimulates Leydig cell steroidogenesis via the cAMP/cGMP signaling pathway.
    Andric SA; Janjic MM; Stojkov NJ; Kostic TS
    Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E544-50. PubMed ID: 20663985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender-specific immunological effects of the phosphodiesterase 5 inhibitor sildenafil in healthy mice.
    Karakhanova S; Yang Y; Link J; Soltek S; von Ahn K; Umansky V; Werner J; Bazhin AV
    Mol Immunol; 2013 Dec; 56(4):649-59. PubMed ID: 23911424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Multifaceted Potential of Sildenafil in Medicine.
    Pușcașu C; Zanfirescu A; Negreș S; Șeremet OC
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing of the PDE5 Inhibitor Sildenafil for the Treatment of Persistent Pulmonary Hypertension in Neonates.
    Poitras EL; Gust SL; Kerr PM; Plane F
    Curr Med Chem; 2021; 28(12):2418-2437. PubMed ID: 32964819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD.
    García-Barroso C; Ricobaraza A; Pascual-Lucas M; Unceta N; Rico AJ; Goicolea MA; Sallés J; Lanciego JL; Oyarzabal J; Franco R; Cuadrado-Tejedor M; García-Osta A
    Neuropharmacology; 2013 Jan; 64():114-23. PubMed ID: 22776546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cGMP phosphodiesterase 5 suppresses matrix metalloproteinase-2 production in pulmonary artery smooth muscles cells.
    Sun XZ; Li ZF; Liu Y; Fang P; Li MX
    Clin Exp Pharmacol Physiol; 2010 Mar; 37(3):362-7. PubMed ID: 19793106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of an ultra performance liquid chromatography tandem mass method for sildenafil and N-desmethyl sildenafil plasma determination and quantification.
    Simiele M; Pensi D; Pasero D; Ivaldi F; Rinaldi M; Di Perri G; Ranieri VM; D'Avolio A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():35-40. PubMed ID: 26253809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the phosphodiesterase 5 inhibitors sildenafil, tadalafil and vardenafil on rat anococcygeus muscle: functional and biochemical aspects.
    Toque HA; Priviero FB; Zemse SM; Antunes E; Teixeira CE; Webb RC
    Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):358-66. PubMed ID: 18986324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer's disease.
    Zuccarello E; Acquarone E; Calcagno E; Argyrousi EK; Deng SX; Landry DW; Arancio O; Fiorito J
    Biochem Pharmacol; 2020 Jun; 176():113818. PubMed ID: 31978378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sildenafil on renin secretion in human subjects.
    Chiu YJ; Reid IA
    Exp Biol Med (Maywood); 2002 Sep; 227(8):620-5. PubMed ID: 12192104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase 5 (PDE5) inhibition, ANP and NO rapidly reduce epididymal duct contractions, but long-term PDE5 inhibition in vivo does not.
    Mietens A; Tasch S; Feuerstacke C; Eichner G; Volkmann J; Schermuly RT; Grimminger F; Müller D; Middendorff R
    Mol Cell Endocrinol; 2012 Feb; 349(2):145-53. PubMed ID: 21996373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous LC-MS/MS analysis of the biomarkers cAMP and cGMP in plasma, CSF and brain tissue.
    Oeckl P; Ferger B
    J Neurosci Methods; 2012 Jan; 203(2):338-43. PubMed ID: 22001223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico design of novel hERG-neutral sildenafil-like PDE5 inhibitors.
    Kayık G; Tüzün NŞ; Durdagi S
    J Biomol Struct Dyn; 2017 Oct; 35(13):2830-2852. PubMed ID: 27581752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of PDE5 inhibitors in heme oxygenase-cGMP relationship in rat cavernous tissues.
    Aziz MT; Mostafa T; Atta H; Rashed L; Marzouk SA; Obaia EM; Sabry D; Hassouna AA; El-Shehaby AM; Aziz AT
    J Sex Med; 2008 Jul; 5(7):1636-45. PubMed ID: 18208506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sildenafil on platelet function and platelet cGMP of patients with erectile dysfunction.
    Akand M; Gencer E; Yaman Ö; Erişgen G; Tekin D; Özdiler E
    Andrologia; 2015 Dec; 47(10):1098-102. PubMed ID: 25486996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol and sildenafil synergistically improve diabetes-associated erectile dysfunction in streptozotocin-induced diabetic rats.
    Bai Y; An R
    Life Sci; 2015 Aug; 135():43-8. PubMed ID: 26006044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple affinity states of cGMP-specific phosphodiesterase for sildenafil inhibition defined by cGMP-dependent and cGMP-independent mechanisms.
    Rybalkina IG; Tang XB; Rybalkin SD
    Mol Pharmacol; 2010 Apr; 77(4):670-7. PubMed ID: 20086037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.